Han-Sung Jung
Director/Board Member at PSOMAGEN, INC.
Net worth: 338 953 $ as of 2024-04-29
Profile
Han-Sung Jung is currently an Independent Director at Psomagen, Inc. He previously worked as an Auditor at Macrogen, Inc., Kainos Medicine, Inc., and Dx & Vx Co., Ltd.
Mr. Jung holds a graduate degree from Seoul National University and Seikei University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 95,899 ( 0.50% ) | 338 953 $ | 2024-04-29 |
Han-Sung Jung active positions
| Companies | Position | Start |
|---|---|---|
| PSOMAGEN, INC. | Director/Board Member | - |
Former positions of Han-Sung Jung
| Companies | Position | End |
|---|---|---|
| MACROGEN, INC. | Comptroller/Controller/Auditor | 2014-03-27 |
| DX & VX CO., LTD. | Comptroller/Controller/Auditor | - |
Kainos Medicine, Inc. /old/
 Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | - |
Training of Han-Sung Jung
| Seoul National University | Graduate Degree |
| Seikei University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MACROGEN, INC. | Health Services |
| DX & VX CO., LTD. | Health Technology |
| PSOMAGEN, INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Han-Sung Jung
